Literature DB >> 18052646

[Spanish translation, adaptation, and validation of the 32-item questionnaire on quality of life for inflammatory bowel disease(IBDQ-32)].

M Masachs1, F Casellas, J R Malagelada.   

Abstract

INTRODUCTION: The measurement of health-related quality of life (HRQoL) has an established relevance in the assessment, management, and follow-up of inflammatory bowel disease. The most commonly used measuring instrument is the 32-item version of Inflammatory Bowel Disease Questionnaire (IBDQ-32), which has never been adapted to Spanish.
OBJECTIVE: To translate IBDQ-32 into Spanish, and to establish its validity, reliability, and sensitivity both in ulcerative colitis and Crohn s disease.
METHOD: A prospective study in two phases -translation into Spanish and subsequent validation of IBDQ-32. Translation was based on the validated Spanish version of IBDQ-36, and IBDQ-32 items not included in IBDQ-36 were translated from scratch. Once the IBDQ32 translation was completed a comprehension-specific questionnaire was administered. To establish IBDQ-32 psychometric properties a group of patients completed both the validated Spanish version of IBDQ-36 and IBDQ-32.
RESULTS: Eighty-four patients (53 with Crohn s disease and 31 with ulcerative colitis) were included. Median overall scores in both questionnaires for all 84 patients did not differ (6.1 vs. 6.2, p = ns), and Spearman s correlation was highly significant (r = 0.97, p < 0.001). The ability to discriminate between patients in flare-up or remission was also equivalent for both questionnaires (6.4 vs. 6.4 with r = 0.96 in remission and 3.8 vs. 3.9 with r = 0.95 active, p < 0.001 for remission vs. activity). These results were obtained in both the analyses for CD and UC independently (6.4 vs. 6.4 and 6.7 vs. 6.6, respectively; p = ns).
CONCLUSION: The Spanish version of IBDQ-32 is valid and discriminating for patients with Crohn s disease or ulcerative colitis.

Entities:  

Mesh:

Year:  2007        PMID: 18052646     DOI: 10.4321/s1130-01082007000900006

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  5 in total

Review 1.  Assessing patient reported outcome measures: A practical guide for gastroenterologists.

Authors:  Laith Alrubaiy; Hayley A Hutchings; John G Williams
Journal:  United European Gastroenterol J       Date:  2014-12       Impact factor: 4.623

2.  Cultural Adaptation and Validation of the Inflammatory Bowel Disease Disability Index in a Spanish Population and Its Association with Sociodemographic and Clinical Factors.

Authors:  Rafael López-Cortés; Raquel Herrero-Hahn; Rosanna De la Rosa-Eduardo; Rafael Montoya-Juárez; María Paz García-Caro; Blanca Marín-Fernández; César Hueso-Montoro
Journal:  Int J Environ Res Public Health       Date:  2019-02-21       Impact factor: 3.390

3.  Quality of Life in Cohabitants of Patients Suffering Inflammatory Bowel Disease: A Cross-Sectional Study.

Authors:  Manuel López-Vico; Antonio D Sánchez-Capilla; Eduardo Redondo-Cerezo
Journal:  Int J Environ Res Public Health       Date:  2021-12-23       Impact factor: 3.390

4.  Depression and Anxiety Disorders Impact in the Quality of Life of Patients with Inflammatory Bowel Disease.

Authors:  Jesús K Yamamoto-Furusho; Katya E Bozada Gutiérrez; Andrea Sarmiento-Aguilar; Ana Fresán-Orellana; Perla Arguelles-Castro; Mario García-Alanis
Journal:  Psychiatry J       Date:  2021-10-27

5.  Systematic Review of Development and Content Validity of Patient-reported Outcome Measures in Inflammatory Bowel Disease: Do We Measure What We Measure?

Authors:  Emma M van Andel; Brechtje D M Koopmann; Femke Crouwel; Casper G Noomen; Nanne K H de Boer; Dirk P van Asseldonk; Lidwine B Mokkink
Journal:  J Crohns Colitis       Date:  2020-09-16       Impact factor: 9.071

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.